SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Windlas Biotech - Quaterly Results

12 Nov 2024 Evaluate
The Revenue for the quarter ended  September 2024 of Rs. 1870.01 millions grew by 22.49 % from Rs. 1526.72 millions.A slim rise of 11.60% was recorded in the Net profit for the quarter ended September 2024 to Rs. 156.58  millions  From Rs. 140.31 millions.Operating profit surged to 278.90 millions from the corresponding previous quarter of 219.27 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 1870.01 1526.72 22.49 3621.54 2974.58 21.75 6309.56 5130.83 22.97
Other Income 48.41 32.40 49.41 89.74 58.64 53.04 134.68 99.65 35.15
PBIDT 278.90 219.27 27.19 529.03 416.94 26.88 915.70 702.07 30.43
Interest 11.03 2.85 287.02 15.95 5.22 205.56 11.03 7.86 40.33
PBDT 267.87 216.42 23.77 513.08 411.72 24.62 904.67 694.21 30.32
Depreciation 65.01 33.30 95.23 127.11 65.19 94.98 134.44 123.64 8.74
PBT 202.86 183.12 10.78 385.97 346.53 11.38 770.23 570.57 34.99
TAX 46.28 42.81 8.11 94.60 85.56 10.57 188.79 144.13 30.99
Deferred Tax -5.04 -0.91 453.85 -2.84 2.03 -239.90 15.35 0.63 2336.51
PAT 156.58 140.31 11.60 291.37 260.97 11.65 581.44 426.44 36.35
Equity 104.50 103.99 0.49 104.50 103.99 0.49 103.99 104.63 -0.61
PBIDTM(%) 14.91 14.36 3.84 14.61 14.02 4.22 14.51 13.68 6.06

Windlas Biotech Share Price

861.65 -34.05 (-3.80%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×